Cabozantinib | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cabozantinib
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Cabozantinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 10 USDMF, 2 EU WC, 2 KDMF, 13 NDC API, 22 Listed Suppliers, $ API Reference Price

29 API Suppliers
10 USDMF
2 EU WC
2 KDMF
13 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

72 Drugs in Development

72 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 3 Canada, 12 Australia, 7 Listed Dossiers

41 FDF Dossiers
8 FDA Orange Book
11 Europe
3 Canada
12 Australia
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 80MG BASE

CAPSULE;ORAL - EQ 20MG BASE
CAPSULE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 10 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 21 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 33 Fillers, Diluents & Binders, 23 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 19 Controlled & Modified Release, 14 Lubricants & Glidants, 13 Direct Compression, 12 Film Formers & Plasticizers, 12 Granulation, 9 Empty Capsules, 6 Co-Processed Excipients, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Coloring Agents, 4 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Solubilizers, 3 Chewable & Orodispersible Aids, 1 Parenteral

46 Coating Systems & Additives
33 Fillers, Diluents & Binders
23 Disintegrants & Superdisintegrants
20 Thickeners and Stabilizers
19 Controlled & Modified Release
14 Lubricants & Glidants
13 Direct Compression
12 Film Formers & Plasticizers
12 Granulation
9 Empty Capsules
6 Co-Processed Excipients
5 Emulsifying Agents
5 Rheology Modifiers
5 Coloring Agents
4 Topical
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
3 Solubilizers
3 Chewable & Orodispersible Aids
1 Parenteral

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 165 News #PharmaBuzz

2 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
165 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 10 Annual Reports

2 US Medicaid Prescriptions
9 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

64 US Patents, 6 US Exclusivities

64 US Patents
6 US Exclusivities

REF. STANDARDS & IMPURITIES

10 Others

10 Others

$ API Ref.Price (USD/KG) : 19,403 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 6EXELIXIS INC

filter Product Reset all filters

6 All

01 6CABOZANTINIB S-MALATE

filter Exclusivity Expiration Date Reset all filters

6 All

01 32026-01-14

02 32028-09-17

filter Exclusivity Code Reset all filters

6 All

01 3ODE-227

02 3ODE-375

Product Main Page

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-227

Exclusivity Expiration Date

2026-01-14

Application Number

208692

Product Number

3

Exclusivity Details

01

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-227

Exclusivity Expiration Date : 2026-01-14

Application Number : 208692

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-375

Exclusivity Expiration Date

2028-09-17

Application Number

208692

Product Number

1

Exclusivity Details

02

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-375

Exclusivity Expiration Date : 2028-09-17

Application Number : 208692

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-227

Exclusivity Expiration Date

2026-01-14

Application Number

208692

Product Number

1

Exclusivity Details

03

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-227

Exclusivity Expiration Date : 2026-01-14

Application Number : 208692

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-375

Exclusivity Expiration Date

2028-09-17

Application Number

208692

Product Number

2

Exclusivity Details

04

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-375

Exclusivity Expiration Date : 2028-09-17

Application Number : 208692

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-227

Exclusivity Expiration Date

2026-01-14

Application Number

208692

Product Number

2

Exclusivity Details

05

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-227

Exclusivity Expiration Date : 2026-01-14

Application Number : 208692

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

EXELIXIS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CABOZANTINIB S-MALATE

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Exclusivity Code

ODE-375

Exclusivity Expiration Date

2028-09-17

Application Number

208692

Product Number

3

Exclusivity Details

06

EXELIXIS INC

CABOZANTINIB S-MALATE

Cancer Research

Not Confirmed

EXELIXIS INC

U.S.A

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CABOZANTINIB S-MALATE

Exclusivity Code : ODE-375

Exclusivity Expiration Date : 2028-09-17

Application Number : 208692

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!